Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

Share Price is delayed by 15 minutes
Get Live Data
222.00    -5.00 (-2.20%)
Bid:
222.00
Ask:
232.00
Spread: 10.00 (4.505%)
Market Cap: £117.21m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Share Chart

Interim Management Statement

13 May 2013 07:00

RNS Number : 4884E
Microgen PLC
13 May 2013
 



microgen

www.microgen.com

 

13 May 2013

 

INTERIM MANAGEMENT STATEMENT

 

 

Microgen plc ('Microgen' or 'Group') provides its Interim Management Statement covering the period from 1 January 2013 to the date of this announcement. Microgen released its final results for the year ending 31 December 2012 on 25 February 2013.

 

There have been no significant changes since 1 January 2013 in the financial position of Microgen and its balance sheet remains strong. The Group had net cash at 30 April 2013 of £32.3 million (31 December 2012 : £32.1 million) before payment of the dividend and special dividend totalling £6.1 million, scheduled for 28 May 2013.

 

The Board remains satisfied with the financial performance of the Group with benefit continuing to be received from its conservative operational approach and annual licencing model. The Financial Systems Division has commenced delivery of a significant 5Series project with a large global bank and continues to perform satisfactorily. The Microgen Aptitude Solutions Division ("MASD") has started implementation of a major new financial services project in North America based on both Microgen Aptitude and Accounting Hub. In addition, MASD has further strengthened its intellectual property portfolio with three new patents being granted by the US Patent Office since 1 January 2013 in respect of the Microgen Aptitude technology.

 

Strategic Review

 

The Microgen Group continues to be financially very robust with a strong balance sheet and consistent profitability/cash flow. Following payment of the dividend and special dividend, through the Board's pro-active shareholder realisation programme, Microgen will have returned to shareholders 100% of the market capitalisation as at 13 October 2008 via dividends, special dividends, tender offers and share buy-backs.

 

The Microgen Aptitude technology and related applications (e.g. Microgen Accounting Hub) continue to be affirmed as being market leading. Originally targeted at the financial services sector, which remains the core of the business, Microgen Aptitude has also established a strong reputation in the digital media sector and is now developing opportunities in both the telecom and healthcare sectors.

 

The Financial Systems Division operates in more established product categories with high recurring revenues. The core business which operates within the financial services sector has been stable for a number of years and continues to provide predictable cash flows. Furthermore, the investment in the development of the 5Series Trust & Fund administration product and an increasingly active wealth management market, have resulted in a number of new customer wins during the past year as well as upgrades from the previous 4Series product version.

 

Notwithstanding these strengths and the success of the shareholder realisation programme since October 2008, Microgen is constrained as a result of being a small, independent public company. As a provider of enterprise solutions in a risk-averse market environment, the size of the group can be an inhibitor given the very large enterprise software companies with which MASD typically competes. As a result, the Board has determined this to be an appropriate time to evaluate the Group's future strategy to maximise the potential of Microgen's market-leading technology and applications and has therefore decided to undertake a strategic review of the Group.

 

Given the financial strength of Microgen, continuing with the current strategy and structure remains a viable option. Nevertheless, the strategic review will be wide-ranging and may, or may not, result in the disposal of one or both of the operating divisions. Alternatively, the Board will also consider the merits of acquisition(s) to increase the scale of the Group, including acquisition(s) which may or may not provide operating synergies with the current operating divisions. Investec Bank Plc has been appointed to assist the Board in the strategic review.

 

The Board anticipates that this process will take several months. Further announcements will be made as appropriate.

 

 

 

 

 

 

 

Contacts

Martyn Ratcliffe, Chairman 020-7496-8100

David Sherriff, Chief Executive Officer

Philip Wood, Group Finance Director

 

James Melville-Ross, FTI Consulting 020-7831-3113

Lucy Delaney, FTI Consulting

 

Rowena Murray, Investec Bank Plc 020-7597 5970

Andrew Pinder, Investec Bank Plc

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSAMMATMBABBTJ
Date   Source Headline
8th Nov 20132:13 pmRNSHolding(s) in Company
6th Nov 20134:49 pmRNSHolding(s) in Company
6th Nov 20134:46 pmRNSHolding(s) in Company
1st Nov 20131:31 pmRNSPosting of Shareholder Circular
29th Oct 20137:02 amRNSStrategic Review
29th Oct 20137:00 amRNSInterim Management Statement
28th Oct 20134:32 pmRNSHolding(s) in Company
23rd Oct 20131:01 pmRNSHolding(s) in Company
1st Oct 201312:51 pmRNSDirector Declaration
26th Sep 20132:26 pmRNSBlocklisting Interim Review
25th Sep 20134:32 pmRNSHolding(s) in Company
9th Aug 20137:00 amRNSDirectorate Change
22nd Jul 20137:00 amRNSInterim Results
17th Jul 20132:36 pmRNSHolding(s) in Company
15th Jul 20132:19 pmRNSNotice of Interim Results
2nd Jul 20133:16 pmRNSBlocklisting Return
1st Jul 201310:14 amRNSTotal Voting Rights
27th Jun 20131:57 pmRNSHolding(s) in Company
3rd Jun 20139:50 amRNSTotal Voting Rights
13th May 201311:53 amRNSResults of AGM
13th May 20137:00 amRNSInterim Management Statement
1st May 20137:00 amRNSTotal Voting Rights
29th Apr 20135:23 pmRNSHolding(s) in Company
29th Apr 20135:16 pmRNSHolding(s) in Company
9th Apr 201312:11 pmRNSHolding(s) in Company
8th Apr 20135:20 pmRNSHolding(s) in Company
5th Apr 20134:35 pmRNSHolding(s) in Company
2nd Apr 201310:58 amRNSTotal Voting Rights
25th Mar 20134:06 pmRNSBlocklisting Interim Review
21st Mar 20134:53 pmRNSAnnual Information Update
21st Mar 20133:33 pmRNSDirectors Shareholdings
21st Mar 20133:28 pmRNSPDMR Shareholding
8th Mar 20132:37 pmRNSPosting of Annual Report and Notice of AGM
25th Feb 20137:00 amRNSPreliminary Results
19th Feb 20137:00 amRNSNotice of Results
4th Jan 201310:03 amRNSBlocklisting Interim Review
30th Nov 20129:24 amRNSTotal Voting Rights
12th Nov 20127:00 amRNSInterim Management Statement
31st Oct 20123:01 pmRNSTotal Voting Rights
23rd Oct 20122:12 pmRNSHolding(s) in Company
28th Sep 20122:15 pmRNSBlocklisting Interim Review
31st Aug 201210:00 amRNSTotal Voting Rights
31st Jul 20129:51 amRNSTotal Voting Rights
26th Jul 20127:00 amRNSTransaction in Own Shares
25th Jul 20127:00 amRNSTransaction in Own Shares
23rd Jul 20127:00 amRNSInterim Results
13th Jul 201210:32 amRNSNotice of Results
4th Jul 201211:12 amRNSBlocklisting Interim Review
2nd Jul 201211:29 amRNSTotal Voting Rights
30th Apr 20129:44 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.